Xcout Intel
Aspect Biosystems
Aspect Biosystems develops bioengineered cellular medicines and implantable tissue therapeutics using a proprietary bioprinting platform that integrates AI, computational design, and advanced biomaterials. The company serves the biotechnology and pharmaceutical industries by creating treatments to replace, repair, or supplement biological functions for metabolic and endocrine diseases.
Subscribe to see Aspect Biosystems’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Aspect Biosystems at a glance
Aspect Biosystems is a biotech company headquartered in Vancouver, Canada. Xcout tracks 11 named people at Aspect Biosystems, including Ray Smith (Chief Financial Officer). Xcout recorded 20 job postings from Aspect Biosystems in the last 90 days.
Aspect Biosystems leadership
- Ray SmithChief Financial Officer
- Simon BeyerChief Technology Officer
- Leela ParisChief Technical Operations Officer
- Mike ScottChief Development Officer
- Sam WadsworthChief Scientific Officer
- Tamer MohamedFounder & CEO
5 more named people on record for Aspect Biosystems, with roles, board committees and tenure — see the full roster →
Hiring at Aspect Biosystems
Xcout recorded 20 job postings from Aspect Biosystems in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see Aspect Biosystems's hiring signals →
Tech stack
Aspect Biosystems competitors
A few of Aspect Biosystems's closest competitors — see the full list of competitors and alternatives →
AbCellera is a biotechnology company that integrates biology, computation, and engineering to discover and develop antibody-based medicines. The company operates a proprietary technology platform to advance internal and partnered drug programs across therapeutic areas such as endocrinology, immunology, autoimmunity, and oncology.
iOrganBio is a biotechnology company founded in 2024 that develops AI-powered platforms for the precision engineering and manufacturing of human cells and organoids. The company's CellForge platform aims to create reproducible human cell models for research applications, including cardiac disease studies and biological simulation.
Somite Therapeutics, Inc. is a biotechnology research company founded in 2023 and based in Massachusetts, United States, that utilizes artificial intelligence to produce human tissue for therapeutic applications.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Get Aspect Biosystems's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Aspect Biosystems? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Aspect Biosystems in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access